Literature DB >> 17655374

Considerations in drug handling in renal disease.

Domenic A Sica1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17655374     DOI： 10.2165/00003088-200746080-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  7 in total

Review 1.  Prediction equations to estimate glomerular filtration rate: an update.

Authors:  G Manjunath; M J Sarnak; A S Levey
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-11       Impact factor: 2.894

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Authors:  William H Frishman; Mamata Alwarshetty
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Diuretic therapy.

Authors:  D C Brater
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

Review 5.  Kinetics of angiotensin-converting enzyme inhibitors in renal failure.

Authors:  D A Sica
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

6.  Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment.

Authors:  Sujata Vaidyanathan; Hilde Bigler; ChingMing Yeh; Marie-Noelle Bizot; Hans Armin Dieterich; Dan Howard; William P Dole
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 7.  Hypertension, renal disease, and drug considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738
  7 in total
  1 in total

Review 1.  Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

Authors:  Roger K Verbeeck; Flora T Musuamba
Journal:  Eur J Clin Pharmacol       Date:  2009-06-20       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.